BiotechTube

XR-NTX 380 mg, intramuscular injection + Placebo intramuscular injection

ApprovedRecruiting
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Alcohol Use Disorder

Conditions

Alcohol Use Disorder, Alcoholism

Trial Timeline

Mar 7, 2022 → Jul 1, 2028

NCT ID
NCT05028062

About XR-NTX 380 mg, intramuscular injection + Placebo intramuscular injection

XR-NTX 380 mg, intramuscular injection + Placebo intramuscular injection is a approved stage product being developed by Alkermes for Alcohol Use Disorder. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05028062. Target conditions include Alcohol Use Disorder, Alcoholism.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT05028062ApprovedRecruiting

Competing Products

20 competing products in Alcohol Use Disorder

See all competitors
ProductCompanyStageHype Score
VK2809 + PlacebosViking TherapeuticsPhase 2
47
TERN-501 + TERN-101Terns PharmaceuticalsPhase 2
49
TERN-101Terns PharmaceuticalsPhase 2
49
TERN-201Terns PharmaceuticalsPhase 1
30
IVA337 + IVA337 + PlaceboInventivaPhase 2
47
LanifibranorInventivaPhase 2
47
IVA337 + Placebo + EmpagliflozinInventivaPhase 2
47
IVA337 + PlaceboInventivaPhase 3
72
LY686017 + PlaceboEli LillyPhase 2
52
LY3537031 + PlaceboEli LillyPhase 3
77
AD04 (ondansetron) + Matching placeboAdial PharmaceuticalsPhase 3
69
GODEX + PlaceboCelltrionPhase 3
77
Colesevelam HclDaiichi SankyoPhase 2
52
ASP9831 + PlaceboAstellas PharmaPhase 2
52
ASP8062 + PlaceboAstellas PharmaPhase 2
52
LY686017 + PlaceboEli LillyPhase 2
52
Mazdutide + PlaceboEli LillyPhase 2
52
opioid receptor kappa antagonistEli LillyPhase 1
33
Tirzepatide + PlaceboEli LillyPhase 2
52
LY2196044 + placeboEli LillyPhase 2
52

Other Products from Alkermes

Naltrexone for extended-release injectable suspension + Oral naltrexoneApproved
82
Aripiprazole LauroxilApproved
82
VIVITROL 380 mg + PlaceboApproved
82
Aripiprazole LauroxilApproved
82
Extended release injectable naltrexone (Vivitrol)Approved
82